L. Eller

发表

Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys

Jerome H. Kim, B. Korber, P. Earl, 2013, Cell.

Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors

M. Robb, B. Gunn, G. Alter, 2021, Frontiers in Immunology.

Expansion of Stem Cell-Like CD4+ Memory T Cells during Acute HIV-1 Infection Is Linked to Rapid Disease Progression

M. Robb, G. Alter, S. Nitayaphan, 2019, Journal of Virology.

Hepatitis and tuberculosis testing are much less common than HIV testing among adults in Kisumu, Kenya: results from a cross-sectional assessment

M. Robb, Victorine Owira, M. de Souza, 2021, BMC Public Health.

Chikungunya and O’nyong-nyong Viruses in Uganda: Implications for Diagnostics

M. Robb, N. Michael, L. Hensley, 2019, Open forum infectious diseases.

Chikungunya in Uganda: Sometimes the Hoof Beats Really Are Zebras

M. Robb, N. Michael, L. Hensley, 2017 .

Epidemiological and clinical implications of asymptomatic malaria and schistosomiasis co-infections in a rural community in western Kenya

Victorine Owira, M. de Souza, E. Kamau, 2021, BMC Infectious Diseases.

Combining Viral Genetics and Statistical Modeling to Improve HIV-1 Time-of-Infection Estimation towards Enhanced Vaccine Efficacy Assessment

Simon A. A. Travers, Lindsay N. Carpp, J. P. Labuschagne, 2019, Viruses.

Preferential and persistent impact of acute HIV-1 infection on CD4+ iNKT cells in colonic mucosa

J. Ananworanich, J. K. Sandberg, M. Robb, 2021, Proceedings of the National Academy of Sciences.

Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection

Phuc T. Pham, Jerome H. Kim, B. Korber, 2017, PLoS pathogens.

Transient Reductions in Human Immunodeficiency Virus (HIV) Clinic Attendance and Food Security During the Coronavirus Disease 2019 (COVID-19) Pandemic for People Living With HIV in 4 African Countries

L. Francisco, A. Esber, L. Eller, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Large-Scale Human Immunodeﬁciency Virus Rapid Test Evaluation in a Low-Prevalence Ugandan Blood Bank Population (cid:1)

S. Peel, M. Robb, N. Michael, 2007 .

Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge.

Jerome H. Kim, P. Earl, B. Moss, 2012, Vaccine.

Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study.

G. Olinger, M. Robb, N. Michael, 2015, Lancet. Infectious Diseases (Print).

Nautilus: a bioinformatics package for the analysis of HIV type 1 targeted deep sequencing data.

Phuc T. Pham, Jerome H. Kim, E. Sanders-Buell, 2013, AIDS research and human retroviruses.

Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand

J. P. Labuschagne, Phuc T. Pham, Bethany L. Dearlove, 2020, PLoS pathogens.

Evolution of HIV-1 within untreated individuals and at the population scale in Uganda

C. Fraser, K. Lythgoe, Chieh-Hsi Wu, 2018, PLoS pathogens.

HLA-B∗46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotype.

T. Holtz, R. Clifford, R. Apps, 2022, Cell host & microbe.

High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR.

F. Mccutchan, N. Michael, F. Wabwire-mangen, 2009, Tissue antigens.

Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate.

P. Earl, B. Moss, D. Montefiori, 2007, Virology.

Assessment of tuberculosis disease activity in people infected with Mycobacterium tuberculosis and living with HIV: A longitudinal cohort study

M. Hoelscher, A. Esber, L. Eller, 2022, EClinicalMedicine.

Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+ T cells

Hongjun Bai, D. Douek, J. Ananworanich, 2022, EBioMedicine.

Decreased Seroreactivity in Individuals Initiating Antiretroviral Therapy during Acute HIV Infection

J. Ananworanich, S. Peel, L. Jagodzinski, 2019, Journal of Clinical Microbiology.

Differential Loss of Invariant Natural Killer T Cells and FoxP3+ Regulatory T Cells in HIV-1 Subtype A and Subtype D Infections

O. Laeyendecker, T. Quinn, M. Robb, 2013, Journal of acquired immune deficiency syndromes.

Innate and Adaptive Immune Responses Both Contribute to Pathological CD4 T Cell Activation in HIV-1 Infected Ugandans

N. Sewankambo, O. Laeyendecker, T. Quinn, 2011, PloS one.

P10-12. Altered NK cell phenotype and function in Ugandans with chronic HIV-1 infection

D. Guwatudde, M. de Souza, F. Wabwire-mangen, 2009, Retrovirology.

Sex and Urbanicity Contribute to Variation in Lymphocyte Distribution across Ugandan Populations

M. Robb, D. Guwatudde, M. de Souza, 2016, PloS one.

Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes.

P. Rosenthal, H. Hatano, D. Havlir, 2010, Journal of virological methods.

Longitudinal Analysis of Peripheral and Colonic CD161+ CD4+ T Cell Dysfunction in Acute HIV-1 Infection and Effects of Early Treatment Initiation

J. Ananworanich, M. Robb, S. Nitayaphan, 2020, Viruses.

The Association Between Heterosexual anal Intercourse and HIV Acquisition in Three Prospective Cohorts of Women.

A. van der Straten, M. Boily, M. Maheu-Giroux, 2023, AIDS and behavior.

Assessing Prevalence and Transmission Rates of Malaria through Simultaneous Profiling of Antibody Responses against Plasmodium and Anopheles Antigens

S. Chaudhury, E. Bergmann-Leitner, E. Kamau, 2022, Journal of clinical medicine.

B Cell Depletion in HIV-1 Subtype A Infected Ugandan Adults: Relationship to CD4 T Cell Count, Viral Load and Humoral Immune Responses

D. Montefiori, M. Robb, M. de Souza, 2011, PloS one.

Determining hematological, biochemical and immunological reference values in healthy adults with high-risk for HIV acquisition in Mozambique

M. Robb, N. Michael, I. Jani, 2020, PloS one.

Relatively Low HIV Infection Rates in Rural Uganda, but with High Potential for a Rise: A Cohort Study in Kayunga District, Uganda

M. Robb, F. McCutchan, D. Guwatudde, 2009, PloS one.

Clinical signs and symptoms associated with acute HIV infection from an intensely monitored cohort on 2 continents

Jerome H. Kim, M. Robb, S. Nitayaphan, 2022, Medicine.

This is an open-access article distributed under the terms...

M. Robb, M. de Souza, N. Michael, 2008 .

Higher HIV-1 Incidence and Genetic Complexity Along Main Roads in Rakai District, Uganda

N. Sewankambo, M. Robb, D. Birx, 2006, Journal of acquired immune deficiency syndromes.

Terminal Effector CD8 T Cells Defined by an IKZF2+IL-7R− Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular Cytotoxicity

J. Baeten, T. Quinn, H. Ljunggren, 2019, The Journal of Immunology.

Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial

Mario Roederer, Zonghui Hu, Robert T Bailer, 2015, The Lancet.

Multi-omics analyses reveal that HIV-1 alters CD4 T cell immunometabolism to fuel virus replication

Xian Chen, M. Robb, R. Sékaly, 2021, Nature Immunology.

Factors associated with sexually transmitted infections among care-seeking adults in the African Cohort Study

L. Francisco, A. Esber, L. Eller, 2021, BMC Public Health.

Large-Scale Human Immunodeficiency Virus Rapid Test Evaluation in a Low-Prevalence Ugandan Blood Bank Population

S. Peel, M. Robb, M. de Souza, 2007, Journal of Clinical Microbiology.

Factors influencing estimates of HIV-1 infection timing using BEAST

Lydia Bonar, Morgane Rolland, Merlin L. Robb, 2021, PLoS Comput. Biol..

Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies

E. Sanders-Buell, M. Robb, G. Ferrari, 2023, Journal of virology.

Expansion of Inefficient HIV-Specific CD8 T Cells during Acute Infection

Jerome H. Kim, M. Betts, S. Peel, 2016, Journal of Virology.

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

P. Earl, B. Moss, P. Jahrling, 2004, Nature.

A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).

M. Hoelscher, M. Robb, D. Birx, 2010, The Journal of infectious diseases.

Clinical laboratory reference values in adults in Kisumu County, Western Kenya; hematology, chemistry and CD4

M. Robb, L. Otieno, E. Kamau, 2021, PloS one.

Quality Monitoring of HIV-1-Infected and Uninfected Peripheral Blood Mononuclear Cell Samples in a Resource-Limited Setting

M. Robb, M. de Souza, N. Michael, 2010, Clinical and Vaccine Immunology.

Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.

P. Earl, B. Moss, L. Eller, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Viral kinetics in untreated versus treated acute HIV infection in prospective cohort studies in Thailand

J. Ananworanich, M. Robb, N. Michael, 2017, Journal of the International AIDS Society.

Identification of Acute HIV-1 Infection by Hologic Aptima HIV-1 RNA Qualitative Assay

S. Peel, L. Jagodzinski, M. Robb, 2017, Journal of Clinical Microbiology.

Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection

B. Haynes, A. McMichael, M. Betts, 2016, PLoS pathogens.

Targeted deep sequencing of HIV-1 using the IonTorrentPGM platform.

Phuc T. Pham, Jerome H. Kim, E. Sanders-Buell, 2014, Journal of virological methods.

Dynamic MAIT cell response with progressively enhanced innateness during acute HIV-1 infection

J. Ananworanich, M. Robb, S. Nitayaphan, 2020, Nature Communications.

Dynamic MAIT cell response with progressively enhanced innateness during acute HIV-1 infection

J. Ananworanich, M. Robb, S. Nitayaphan, 2020, Nature Communications.

Global variability of the human IgG glycome

C. Gieger, T. Spector, P. McKeigue, 2019, bioRxiv.

HIV-1 infections with multiple founders associate with the development of neutralization breadth

Bethany L. Dearlove, Hongjun Bai, E. Sanders-Buell, 2022, PLoS Pathogens.

Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization Breadth

Hongjun Bai, E. Sanders-Buell, M. Robb, 2021, Journal of virology.

HIV-1 Viral Subtype Differences in the Rate of CD4+ T-Cell Decline Among HIV Seroincident Antiretroviral Naive Persons in Rakai District, Uganda

O. Laeyendecker, T. Quinn, M. Robb, 2009, Journal of acquired immune deficiency syndromes.

Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection.

Oliver Laeyendecker, Noah Kiwanuka, Michael Eller, 2008, The Journal of infectious diseases.

B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies.

J. Mascola, M. Robb, I. Georgiev, 2021, Cell host & microbe.

HIV prevalence and risk behavior among male and female adults screened for enrolment into a vaccine preparedness study in Maputo, Mozambique

M. Robb, N. Michael, N. Hills, 2019, PloS one.

HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study

M. Robb, A. Esber, L. Eller, 2019, PloS one.

Helios expressing regulatory T cells are correlated with decreased IL-2 producing CD8 T cells and antibody diversity in Mozambican individuals living chronically with HIV-1

M. Robb, I. Jani, L. Kestens, 2021, BMC immunology.

1049. Minimal Transient HIV-1 Viremia Following Vaccination Regimens Containing AD26. ZEBOV and MVA-BN-Filo in ART-Suppressed People Living with HIV

L. Jagodzinski, A. Esber, I. Jani, 2021, Open Forum Infectious Diseases.

Noninfectious Comorbidity in the African Cohort Study (AFRICOS).

M. Robb, V. Valcour, N. Michael, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Human Immunodeficiency Virus Type 1 Infection Is Associated with Increased NK Cell Polyfunctionality and Higher Levels of KIR3DL1+ NK Cells in Ugandans Carrying the HLA-B Bw4 Motif

M. Robb, D. Guwatudde, M. de Souza, 2010, Journal of Virology.

HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic cluster.

F. Mccutchan, M. Robb, N. Michael, 2009, Tissue antigens.

Elevated Natural Killer Cell Activity Despite Altered Functional and Phenotypic Profile in Ugandans With HIV-1 Clade A or Clade D Infection

M. Robb, F. McCutchan, D. Guwatudde, 2009, Journal of acquired immune deficiency syndromes.

HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels.

O. Laeyendecker, T. Quinn, M. Robb, 2015, The Journal of infectious diseases.

Dissecting drivers of immune activation in chronic HIV-1 infection

M. Robb, N. Michael, M. Eller, 2022, EBioMedicine.

Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus–Infected Kenyans

M. Robb, N. Michael, M. Eller, 2018, The Journal of infectious diseases.

Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines.

P. Earl, B. Moss, J. Vogt, 2008, Vaccine.

Single-Cell Level Response of HIV-Specific and Cytomegalovirus-Specific CD4 T Cells Correlate With Viral Control in Chronic HIV-1 Subtype A Infection

M. Robb, D. Guwatudde, M. de Souza, 2012, Journal of acquired immune deficiency syndromes.

Short communication: Colony-forming hematopoietic progenitor cells are not preferentially infected by HIV type 1 subtypes A and D in vivo.

T. Quinn, M. Robb, D. Guwatudde, 2012, AIDS research and human retroviruses.

Routine HIV clinic visit adherence in the African Cohort Study

L. Francisco, A. Esber, L. Eller, 2022, AIDS Research and Therapy.

Prevalence and risk factors associated with HIV and syphilis co-infection in the African Cohort Study: a cross-sectional study

L. Francisco, A. Esber, L. Eller, 2021, BMC Infectious Diseases.

Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines.

P. Earl, B. Moss, M. Robb, 2009, Vaccine.

Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir size.

J. Ananworanich, M. Robb, N. Michael, 2018, JCI insight.

HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children

M. Boivin, D. Havlir, P. Bangirana, 2010, AIDS.

Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting

J. Ananworanich, E. Sanders-Buell, M. Robb, 2023, bioRxiv.

Tracking coreceptor switch of the transmitted/founder HIV-1 identifies co-evolution of HIV-1 antigenicity, coreceptor usage and CD4 subset targeting

J. Ananworanich, E. Sanders-Buell, M. Robb, 2023, bioRxiv.

A genetic shift in an escaped transmitted / founder virus guides 1 combinatorial vaccine design against HIV-1 2 3

Jerome H. Kim, D. Kihara, M. Robb, 2021 .

Monocyte activation, HIV, and cognitive performance in East Africa

V. Valcour, M. Eller, L. Eller, 2019, Journal of NeuroVirology.

Terminally differentiated CD8 effector T cells have NK-like features and are potent mediators of HIV-specific ADCC

M. Robb, N. Michael, M. Eller, 2017, Journal of Immunology.

False reactive HIV-1 diagnostic test results in an individual from Kenya on multiple testing platforms-A case report

L. Otieno, M. de Souza, E. Kamau, 2020, IDCases.

Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans.

M. Robb, D. Birx, B. Graham, 2007, Vaccine.

Systematic comparison of HIV-1 Envelope-specific IgG responses induced by different vaccination regimens: Can we steer IgG recognition towards regions of viral vulnerability?

S. McCormack, M. Hoelscher, M. Robb, 2023, Frontiers in Immunology.

Cryptic Multiple HIV-1 Infection Revealed by Early, Frequent, and Deep Sampling during Acute Infection

Phuc T. Pham, Jerome H. Kim, B. Korber, 2014 .

Impact of early ART initiation on performance of cross sectional incidence assays.

O. Laeyendecker, M. Robb, S. Nitayaphan, 2020, AIDS research and human retroviruses.

Acute HIV-1 Infection in Adults in East Africa and Thailand.

M. Robb, L. Eller, M. Rolland, 2016, New England Journal of Medicine.

High-Throughput High-Resolution Class I HLA Genotyping in East Africa

Jerome H. Kim, M. Hoelscher, E. Sanders-Buell, 2010, PloS one.

Reference Intervals in Healthy Adult Ugandan Blood Donors and Their Impact on Conducting International Vaccine Trials

M. Robb, M. Eller, L. Eller, 2008, PloS one.

High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR.

M. Robb, M. Eller, J. Currier, 2009, Tissue antigens.

A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).

M. Hoelscher, M. Robb, D. Birx, 2010, The Journal of infectious diseases.

Early sexual debut is associated with drug use and decreased educational attainment among males and females in Kisumu County, Kenya

Victorine Owira, M. de Souza, L. Eller, 2023, Reproductive Health.